The Mendelian randomization study suggested a protective effect of genetically predicted higher plasma caffeine levels against AD, with an odds ratio of 0.87 (95% CI: 0.76-1.00), although this did not reach statistical significance.
← all excerpts
Association Between Caffeine Intake and Alzheimer's Disease Progression: A Systematic Review.
1
—
—